Last update 20 Mar 2025

Cannabinoids

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cannabinoids, Orthocann, ReneCann
+ [9]
Target
Action
agonists
Mechanism
A3R agonists(Adenosine A3 receptor agonists)
Inactive Indication
Originator Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 1
United States
20 Mar 2024
Alzheimer DiseaseIND Approval
Italy
08 Oct 2024
Amyotrophic Lateral SclerosisIND Approval
Italy
08 Oct 2024
Parkinson DiseaseIND Approval
Italy
08 Oct 2024
Breast CancerPreclinical
Canada
25 Oct 2023
Breast CancerPreclinical
Canada
25 Oct 2023
ArthritisPreclinical
Israel
13 Jul 2022
Inflammatory Bowel DiseasesPreclinical
Israel
13 Jul 2022
Liver CancerPreclinical
Israel
13 Jul 2022
COVID-19Preclinical
United States
23 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
(jfkakniftf) = bdblzgbltm tynlkualjf (zdrccleibb, -0.65 to 0.75)
Positive
15 Sep 2024
Not Applicable
-
URB447 + TH
zfesjrqwtr(ftqvlumcjm) = lysgvcdneq dhpdoghmtq (fwibdunvec )
-
28 Jun 2024
TH + URB447
zfesjrqwtr(ftqvlumcjm) = dhberwouay dhpdoghmtq (fwibdunvec )
Phase 2
12
(Placebo Cannabinoids)
kwhpdrtddd(vpeyqucsgb) = zghoimfocy eattldemra (pniuolxkyr, kdmkuikasa - jgybpdnziw)
-
26 Jan 2023
(Cannabinoids (THC and CBD))
vqtjhzkdzu(hhdfucimnm) = gwkivmlopp mjwqktqidq (wummvbaheg, sdcznvefhv - jhkljjdfrd)
Not Applicable
-
(Rheumatoid Arthritis patients using cannabis)
(ghcvhlgcme) = 17.5% of patients with RA using cannabinoids reported side effects not leading to cessation qmclxsdipl (oyrwggaqcf )
-
01 Jun 2022
Not Applicable
36
smlohzeljb(rqyzcvhcpn) = olpcibspyg jlhopqfwhq (ntlyccupuj )
-
08 Apr 2014
Not Applicable
218
(znayfgoryk): P-Value = 5.48
-
25 May 2011
Placebo
Not Applicable
8
lpccxhllth(jxlnakieal) = ayloappmtd sgkjiayzat (boldubuxzj )
-
20 May 2009
Not Applicable
TH1 | TH2 | TH-17 ...
-
R(+)WIN55,212-2
mqkgsarrkz(rkbghngspd) = tsmieispsk fcikeohacv (joubchpeqo )
Positive
05 Nov 2007
(Control group)
mqkgsarrkz(rkbghngspd) = eqaeslzeiz fcikeohacv (joubchpeqo )
Not Applicable
-
-
(untransfected cells)
tuggveujzv(bbzyqwdhpo) = ebkmedyhah pcstnvfnli (bqdkwkwqge )
-
14 Nov 2001
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free